← Return to Has anyone benefitted from CET neuropathy treatment?

Discussion
dennisntexas avatar

Has anyone benefitted from CET neuropathy treatment?

Neuropathy | Last Active: May 15 10:18am | Replies (13)
Comment receiving replies
Profile picture for John, Volunteer Mentor @johnbishop

@debbiehirsch - Combined Electrochemical Therapy (CET) -- Here is a research paper on the therapy.
-- Clinical Outcomes Utilizing the Combined Electro- chemical Treatment for Peripheral Neuropathy: A Retrospective Study from a Western Clinic
https://nerverenewalnow.com/wp-content/uploads/7.-Clinical-Outcomes-Utilizing-CET-for-PN.pdf
Google Scholar has more articles here - https://scholar.google.com/scholar

@dennisntexas also posted about CET treatment in another discussion and may have some thoughts.

Jump to this post

Replies to "@debbiehirsch - Combined Electrochemical Therapy (CET) -- Here is a research paper on the therapy. --..."
dennisntexas | @dennisntexas | May 13 10:57am

Thanks John for sharing the study on CET. I ask AI to summarize. This is it. Main Takeaways from the CET Peripheral Neuropathy Study

1. Purpose of the Study
- This is a retrospective review of 112 patients treated with Combined Electrochemical Treatment (CET) for peripheral neuropathy.
- CET combines local anesthetic nerve blocks with Electrical Cell Signaling Treatment (EST).

---

⭐ What CET Is
- CET = chemical nerve block + advanced electrical stimulation.
- EST uses complex, varying electronic signals (not simple TENS) designed to stimulate nerve regeneration and prevent nerve accommodation.

---

⭐ Short-Term Results
- 82.4% of patients reported some symptom relief.
- 64.2% reported >25% improvement.
- Symptom relief was independent of neuropathy cause (diabetic, idiopathic, toxic, chemo‑induced, etc.).
- Functional improvement: 68.9% of patients.
- Sleep improvement: 69.5% of those with sleep disturbance.
- Quality of life improvement: 82.5%.
- Overall satisfaction: 75.2%.
- No adverse events were reported.

---

⭐ Long-Term Results
- Long-term follow-up was obtained for 32 patients.
- 53% maintained symptom improvement for 6 months to 4+ years.
- Some patients’ long-term outcomes were affected by other medical conditions.

VIEW AND REPLY